FMP
NASDAQ
0.455 USD
0.001 (0.22%)
Mr. Richard L. Eberly
Healthcare
Diagnostics & Research
https://chembio.com
NASDAQ
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professiona...
0001092662
US1635722093
163572209
555 Wireless Boulevard
631 924 1135
US
188
Oct 18, 2000
0001092662
NASDAQ
Diagnostics & Resear...
Healthcare
163572209
US1635722093
US
0.46
1.86
538.39k
16.71M
-
0.19-1.24
2.21
-
-
-
-
-0.63
-
https://chembio.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.